CME Information

Target Audience

The program should appeal to basic scientists and clinicians in the fields of neurology, physical medicine and rehabilitation, ophthalmology, otolaryngology, urology, dermatology, aesthetic medicine, gastroenterology, and pain management.

Learning Objectives

  • Review the mechanisms of action and pharmacology of various botulinum neurotoxin serotypes and preparations, in order to be aware of their therapeutic effect
  • Evaluate clinical data, evidence-based recommendations, and practical experience in the use of botulinum neurotoxin for multiple and diverse clinical conditions, to properly assess and select appropriate patients for neurotoxin therapy
  • Demonstrate procedures and techniques for neurotoxin injections, to improve clinical skills and optimize patient outcomes
  • Promote interaction and cooperation among a wide range of scientific and clinical disciplines, to advance research and education relevant to the science and therapeutic application of botulinum and other neurotoxins

ACCME Accreditation Statement

Jointly Accredited ProviderIn support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and the International Neurotoxin Association (INA). Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Credit Designation Statement

PHYSICIANS
Albert Einstein College of Medicine-Montefiore Medical Center designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Conflict of Interest Statement

The “Policy on Identification, Mitigation and Disclosure of Relevant Financial Relationships” of Albert Einstein College of Medicine-Montefiore Medical Center requires that faculty participating in any CME/CE activity disclose to the audience any relevant relationships with an ineligible company or companies.* Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to his or her contribution to the activity, will not be permitted to present.

Albert Einstein College of Medicine-Montefiore Medical Center also requires that faculty participating in any CME/CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device, not yet approved in the United States. All financial relationships listed for individuals have been mitigated.

*The ACCME defines an ineligible company as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients

AMERICANS WITH DISABILITIES ACT

Albert Einstein College of Medicine-Montefiore Medical Center and the International Neurotoxin Association fully intend to comply with the legal requirements of the Americans with Disabilities Act. If any participant of this activity is in need of special accommodations, please contact the INA at least two weeks prior to the activity at 212-796-0138.

Einstein Montefiore INA Logos

This activity is jointly provided by Albert Einstein College of Medicine-Montefiore Medical Center and International Neurotoxin Association (INA).

Supported by an educational grant for in-kind contribution of disposable and biological supplies from Allergan Aesthetics, an AbbVie company, an educational grant for in-kind contribution of product from Galderma, and educational grant for in-kind contribution of product from Merz, an educational grant for in-kind contribution of disposable and biological supplies from Abbvie, and an educational grant for in-kind contribution of product from Ipsen.

Join Our Mailing List

Click here to sign up, and then manage your subscription.